Pharmaceutical Supply for Indian Army: Methotrexate and Other Essential Medications Procurement

Work Description - NA

This tender is issued by the Department of Military Affairs, Ministry of Defence, for the supply of a comprehensive range of pharmaceutical items to the Indian Army. The bid, identified by Bid Number GEM/2026/B/7640173, is scheduled to commence on August 11, 2026, at 11:00 AM and conclude on August 12, 2026, at 11:00 AM. The tender encompasses a significant total quantity of 407,316 units across various critical medications. Key items included in the Bill of Quantities (BOQ) are Methotrexate 5mg tablets, Methotrexate 5mg tablets alongside Amantadine 100mg capsules, Haematinic tablets/capsules containing ferrous fumarate (100mg elemental iron) with folic acid (500mcg), Tranexamic acid 500mg in 5ml injection, Bosentan 62.5mg tablets, Adenosine 3mg/ml in 2ml injection, Esmolol 100mg/10ml injection, Labetalol HCl 100mg tablets, Metoprolol 1mg/ml in 5ml injection, Propranolol TR 40mg tablets, Digoxin 0.5mg in 2ml injection, Vasopressin 20 units/ml in 1ml ampoule, Dopamine HCl 40mg/ml in 5ml injection, Aspirin 150mcg tablets, Metoprolol extended-release 50mg, Clonidine 100mcg tablets, and Hydrochlorothiazide 25mg. This procurement is crucial for meeting the healthcare needs of military personnel and is to be delivered to the specified address in Amritsar City.